drugset / Trial / NCT07147972

Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine

NCT07147972

Phase 3 Not yet recruiting 100 enrolled Fayoum University
RandomizedParallel-groupOpen-labelTreatment

Summary

Migraine is a common disabling neurological condition that significantly affects quality of life. While traditional prophylactic treatments (e.g., beta-blockers, antiepileptics) are effective, they may be associated with side effects leading to poor adherence. Recent evidence suggests that nutraceuticals like magnesium, riboflavin, and coenzyme Q10 may provide a safer alternative. This study aims to compare the efficacy and tolerability of these two approaches.

Timeline

Start
2025-08-20
Primary completion
2026-02-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 400 mg
Comparator Propranolol Small molecule 80 mg

Indications